Skip to main content
    C

    Concentra Group Holdings Parent, Inc. (CON)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $43.45
    +0.90 (+2.13%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Concentra Group Holdings Parent, Inc. (CON) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Concentra Group Holdings Parent (CON) trades at 25.3x trailing earnings and 2.4x sales. Its forward P/E is 22.0x. The median P/E across 12 similar companies is 22.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 15.0% higher over the next year. Its free cash flow yield is 4.7%.

    MultipleValue
    P/E (trailing)25.3x
    Forward P/E22.0x
    Price to sales2.4x
    Price to book10.8x
    EV/EBITDA14.5x
    Price to FCF21.4x
    EV/FCF26.9x
    PEGN/A
    FCF yield4.7%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CON

    What is CON's forward P/E ratio?

    Concentra Group Holdings Parent has a forward P/E ratio of 22.0x.

    Is CON stock overvalued?

    GNG's valuation label for CON is Fairly valued. Its P/E of 25.3x compares with a median of 22.1x across 12 similar companies.

    What is CON's price to sales ratio?

    Concentra Group Holdings Parent has a price to sales ratio of 2.4x.